ArticleFrontiers in medicine2021

An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19.

Charles D Bengtson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.